Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Diabetes Therapy
Altea Therapeutics reports positive results for basal insulin transdermal patch
March 2nd, 2007
Altea Therapeutics announces positive clinical results from phase I human clinical studies for its basal insulin transdermal patch showing efficient, sustained and constant delivery of insulin at therapeutic levels. These results were presented at the 11th Annual Drug Delivery Partnerships Conference held in Las Vegas, Nevada, In a glucose-clamp study in normal subjects, Altea Therapeutics achieved constant insulin delivery at therapeutic levels over a 12-hour patch application period. The data show efficient delivery of the applied dose of insulin and demonstrate favorable pharmacodynamics of transdermal insulin delivery when compared to a...
Source: Drug Week (2007-03-02)
|
